Discover trends, market shifts, and competitive outlooks for the biosimilars industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Is the Estimated Market Size of the Biosimilars Market In 2029?
The size of the biosimilars market has experienced rapid expansion in the past few years. It is predicted to rise from $18.65 billion in 2024 to $21.95 billion in 2025, indicating a compound annual growth rate (CAGR) of 17.7%. The factors contributing to this growth during the historic period include a surge in cancer cases, robust economic development in emerging economies, a rise in spending on pharmaceutical R&D, an escalation in healthcare expenses, growing government initiatives, a robust pipeline of medicines, reduced biosimilar expenses, and an increase in patent expiration.
The biosimilars market is projected to experience a swift expansion in the coming years, ballooning to a size of $42.16 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 17.7%. The surge anticipated during this forecast period may be due to the heightened incidence of cancer, a burgeoning demand for prophylaxis with granulocyte colony-stimulating factor (G-CSF), an elevation in healthcare spending, the potential of budding economies, advances in technology, the wide presence of biological drugs, the aging demographic, and increased healthcare outreach. Key trends for the prediction period are predicted to be an emphasis on vigorous R&D for the creation of potent and innovative pharmaceuticals, a focus on M&A as a growth strategy, strategic partnerships establishment, an increase in investments, and the emphasis on artificial intelligence.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2807&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Biosimilars Market?
Chronic diseases such as arthritis, asthma, and cancer are becoming more common, pushing the biosimilars market to grow. Contributing factors to the increase of chronic diseases include longer work hours, lack of physical movement, and poor dietary and drinking habits. As these chronic diseases become more widespread, there is a growing use of biosimilars for treatment. These biosimilars assist in the activation of the immune system, helping it to combat cancer cells. A United Nations article predicts that by 2030, chronic diseases could account for up to 70% of total global deaths. The overall impact of chronic disease could encompass roughly 60% of the global landscape. The estimated surge in chronic diseases is set to increase the demand for biosimilars, thereby driving the growth of the biosimilars market.
Which Primary Segments of the Biosimilars Market Are Driving Growth and Industry Transformations?
The biosimilars market covered in this report is segmented –
1) By Type: Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others
2) By Product: Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins
3) By Application: Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications
Subsegments:
1) By Monoclonal Antibodies: IgG Biosimilars, Non-IgG Biosimilars
2) By Insulin: Rapid-Acting Insulin Biosimilars, Long-Acting Insulin Biosimilars, Premixed Insulin Biosimilars
3) By Erythropoietin: Epoetin Alfa Biosimilars, Darbepoetin Alfa Biosimilars
4) By Granulocyte-Colony Stimulating Factor (G-CSF): Filgrastim Biosimilars, Pegfilgrastim Biosimilars
5) By Other Hormones: Growth Hormones, Hormonal Replacement Therapy Biosimilars
6) By Others: Enzyme Biosimilars, Vaccines, Other Biologics
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=2807&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Biosimilars Market?# Market?
North America was the largest region in the global biosimilars market in 2024. Middle East is expected to be the fastest-growing region in the forecast period. The regions covered in the biosimilars market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Most Significant Market Trends in the Biosimilars Market?
In an effort to stay competitive in the biosimilars market, key companies are centering their strategies around the creation of innovative goods. AMJEVITA has become the initial biosimilar in the U.S. for Humira, a medication used by over a million patients suffering from certain serious inflammatory illnesses. In January 2023, for example, Amgen Inc., a biotech enterprise based in the US, introduced AMJEVITA (adalimumab-atto), an equivalent to Humira (adalimumab), now accessible in the US. AMJEVITA (40 mg) is listed at a wholesale acquisition cost that’s 55% lower than the current list price of Humira. Furthermore, AMJEVITA is offered at a list price that is 5% cheaper than the existing Humira list price.
View the full report here:
https://www.thebusinessresearchcompany.com/report/biosimilar-global-market-report
What Parameters Are Used to Define the Biosimilars Market?
Biosimilars are medications made from living things, though they can be made in a variety of ways and with slightly different materials. Due to the intricacy and high cost of their creation, as well as their molecular size and structure, biosimilars are fundamentally distinct from generic drugs.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2807
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
